These tests are based on the biology of nucleases, enzymes produced by bacteria and cancer cells that break down nucleic acids in a specific way. By targeting the remains of immunogenic nucleic acids released by tissue destruction, the tests help mitigate the attack of the immune system. SOMAprobes aims to provide more sensitive diagnostic kits for sepsis, coronavirus, cancer, and other human conditions.